Stanley R. Hamilton
0000-0002-8331-1052
Publication & Citation Trends
Publications
0 total
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H
Cited by 0
Semantic Scholar
Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201
Cited by 0
Semantic Scholar
A Concordance Study Among 26 NGS Laboratories Participating in the National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) Clinical Trial.
Cited by 1
Semantic Scholar
Oncolytic virus CF33-hNIS monotherapy for the treatment of gastrointestinal (GI) malignancies.
Cited by 3
Semantic Scholar
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E
Cited by 3
Semantic Scholar
A phase II/III study of peri-operative nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of the neoadjuvant pathologic complete response (pCR) rate (ECOG-ACRIN EA2174).
Cited by 16
Semantic Scholar
Next-Generation Sequencing–Based MSI Scoring Predicts Benefit in Mismatch Repair–Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D OA
Cited by 0
Semantic Scholar
Universal germline testing for cancer susceptibility and actionable noncancer disorders among 19,842 patients: Initial findings from the City of Hope INSPIRE study.
Cited by 0
Semantic Scholar
Research Topics
Genetic factors in colorectal cancer
(258)
Colorectal Cancer Treatments and Studies
(198)
Cancer Genomics and Diagnostics
(152)
Colorectal Cancer Screening and Detection
(89)
Lung Cancer Treatments and Mutations
(71)
Affiliations
Rutgers, The State University of New Jersey
Northwestern University
Showa University
University of Maryland, Baltimore
Cedars-Sinai Medical Center